The US-based genomics company Pairwise has closed a $40 million Series C financing round, led by Deerfield Management, with participation from multiple investors, including Aliment Capital, Leaps by Bayer and Corteva, Inc., through its Corteva Catalyst platform.

Investments from the funding round are expected to be used to scale Pairwise’s product pipeline, including seedless berries and pitless cherries (see AgbioNews Jun 5, 2024), as well as advance its Fulcrum Platform (AgbioNews May 23, 2023).

In parallel to Corteva’s equity investment in Pairwise, the two companies have entered into a five-year joint venture collaboration focussing on accelerating the pace of gene edited technologies and developing improved products that are climate resilient. Corteva’s investment in Pairwise is being made through Corteva Catalyst, the Corteva’s new investment and partnership platform.